CAS: 932372-99-1; 2-Bromo-5-Iodophenol
该化合物是一种有机化合物,其特征是酚环上同时存在溴和碘替代物.该化合物的特征是苯环第二位置的溴原子和苯环第五位置的碘原子,这影响其化学反应和物理特性.作为苯环化合物,该化合物具有典型特征,例如,由于氢氧(-OH)组而形成氢结的能力,这促使其在极地溶剂中溶解.卤素(溴和碘)的存在可以增强它的再活性,使其在各种化学合成应用中有用,包括作为有机合成的中间体.此外,该化合物可能展示生物活动,可以在药用化学中加以探索.其分子结构和亚体特征可以影响其熔点,沸点和光谱特性,使其在学术和工业研究中都受到关注.在处理该化合物时,应当采取安全防范措施,因为与卤化有机化合物有关的潜在危害.
- 英文名称2-Bromo-5-Iodophenol
- 中文名称2-溴-5-碘苯酚
- IUPAC名称2-bromo-5-iodophenol
- 其它别名2-Bromo-5-Iodophenol; Vritxtvqjjmqit-Uhfffaoysa-N
- CAS编号932372-99-1
- MFCD编号:MFCD09907878
- 分子式:C6H4BrIO分子量:298.9
- 产品CID: 1970746
- 产品分类有机原料→分子砌块→芳环类化合物→苯类化合物
物理性质
MSDS等安全信息
上下游产品
CAS号755027-18-0 2-溴-5-碘苯甲醚 | CAS号43192-34-3 4-溴-3-甲氧基苯甲醛 | CAS号755027-18-0 2-溴-5-碘苯甲醚合成工艺路线路线简述
- 755027-18-0 = 932372-99-1
反应条件:1.1 Reagents: Boron Tribromide Solvents: Dichloromethane; 30 Min,-10 °C; 1 H,0 °C; 16 H,Rt1.2 Reagents: Sodium Carbonate Solvents: Water
标题:Preparation Of Heteroaryl Compounds For Treating Huntington'S Disease
参考文献:World Intellectual Property Organization]
755027-18-0 = 932372-99-1
反应条件:1.1 Reagents: Boron Tribromide Solvents: Dichloromethane; 0 °C; 3 H,0 °C1.2 Reagents: Water; 0 °C
标题:3-Sulfonyloxyaryl(Mesityl)Iodonium Triflates As 1,2-Benzdiyne Precursors With Activation Via Ortho-Deprotonative Elimination Strategy
作者:Yuan,Haoyin; Yin,Wenhao; Hu,Jili; Li,Yang
参考文献:Nature Communications 日期:2023 卷标:14(1)]
755027-18-0 = 932372-99-1
反应条件:1.1 Reagents: Boron Tribromide Solvents: Dichloromethane; -78 °C; 1 H,-78 °C; -78 °C -> Rt; Overnight,Rt1.2 Reagents: Water; Rt
标题:Nanopatterning By Molecular Polygons
作者:Jester,Stefan-S.; Sigmund,Eva; Hoger,Sigurd
参考文献:Journal Of The American Chemical Society 日期:2011 卷标:133(29) 页码:11062-11065]
111721-74-5 = 932372-99-1
反应条件:1.1 Reagents: Sodium Nitrite,Sulfuric Acid Solvents: Water; 5 - 10 °C1.2 Reagents: Sulfuric Acid,Copper Sulfate; 80 °C
标题:Industrial Preparation Method Of 2-Bromo-5-Iodophenol From O-Nitroaniline
参考文献:China]
= 932372-99-1 [标题:Reaction Conditions
标题:Preparation Of Sulfonamide Derivatives As Pgd2 Receptor Antagonists
参考文献:World Intellectual Property Organization]
755027-18-0 = 932372-99-1
反应条件:1.1 Reagents: Boron Tribromide Solvents: Dichloromethane; -10 °C; 17 H,-10 °C -> Rt1.2 Reagents: Methanol; Rt; 10 Min,Rt
标题:Preparation Of Heterocyclic Nitrogen Compounds As Nlrp3 Inhibitors And Antiinflammatory Agents
参考文献:China]
755027-18-0 = 932372-99-1
反应条件:1.1 Reagents: Boron Tribromide Solvents: Dichloromethane; 30 Min,< 0 °C; 1 H,0 °C; 16 H,Rt
标题:Preparation Of Heterocyclic And Heteroaryl Compounds For Treating Huntington'S Disease
参考文献:World Intellectual Property Organization]
755027-18-0 = 932372-99-1
反应条件:1.1 Reagents: Boron Tribromide Solvents: Dichloromethane; 30 Min,Cooled; 1 H,Cooled; 3 H,Rt1.2 Reagents: Hydrochloric Acid Solvents: Water; Cooled; 1 H,Rt
标题:Method For Producing N-Phenyl-N'-Phenylsulfonylpiperazine Derivative
参考文献:World Intellectual Property Organization]
755027-18-0 = 932372-99-1
反应条件:1.1 Reagents: Boron Tribromide Solvents: Dichloromethane; 0 °C; 16 H,0 °C -> Rt
标题:Preparation Of Trifluoromethyl Alcohols As Modulators Of Rorγt
参考文献:United States]
= 932372-99-1 [标题:Reaction Conditions
标题:Preparation Of Heterocyclic Substituted 1,3,4-Thiadiazole And Pyridazine Compounds And Methods Of Using The Same
参考文献:World Intellectual Property Organization]
= 932372-99-1 [标题:Reaction Conditions
标题:Preparation Of Heteroaryl Compounds For Treating Huntington'S Disease
参考文献:World Intellectual Property Organization
📜4-碘-2-硝基苯胺置于硫酸,铁粉,氯化铵,Sodium Nitrite体系中,用 水 作为反应溶剂,化学反应生成 2-溴-5-碘苯酚
参考文献:一种2-溴-5-碘苯酚的制备方法
标题:一种2-溴-5-碘苯酚的制备方法
摘要:本发明公开了一种2‑溴‑5‑碘苯酚的工业化制备方法.该2‑溴‑5‑碘苯酚的工业化制备方法,以邻硝基苯胺为初始原料,经上碘,重氮化上溴,还原以及重氮化上酚羟基四步反应合成2‑溴‑5‑碘苯酚.本过程得到的2‑溴‑5‑碘苯酚为蓝色固体,纯度97.5%,每步原料转化率分别达到100%,整个过程的总收率达到17%.
海关参考信息
- 2908199090-其他酚的卤化衍生物
2908999090-其他酚的硝化衍生物
2918290000-其他含酚基羧酸
2905199090-其他饱和一元醇 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2010197692-A1
优先权日:2007-07-20
标 题 :Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
发明人：RAMTOHUL YEEMAN K; LI CHUN SING; LECLERC JEAN-PHILIPPE
权利人:MERCK FROSST CANADA LTD
摘要:Bicyclic heteroaromatic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; liver steatosis; and non-alcoholic steatohepatitis.
